SCHEMBL2782788

SCHEMBL2782788

COc1ccccc1CNNCc1c(OC)cccc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.58
▸ MAPT P10636 2/20 0.58
▸ GAA P10253 1/20 0.58
▸ CHRM2 P08172 13/20 0.53
▸ BCHE P06276 5/20 0.53
▸ ACHE P22303 5/20 0.53
▸ CHRM4 P08173 5/20 0.53
▸ CHRM5 P08912 5/20 0.53
▸ CHRM1 P11229 5/20 0.53
▸ CHRM3 P20309 5/20 0.53
▸ GRIN1 Q05586 4/20 0.53
▸ GRIN2A Q12879 4/20 0.53
▸ RECQL P46063 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ THPO P40225 1/20 0.53
▸ MEN1 O00255 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629157 0.85 KDM4E (0.67) ALDH1A1MAPTCHRM2BCHEACHE
SCHEMBL8356889 0.80 TSHR (0.56) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL3866918 0.80 L3MBTL1 (0.66) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL5695121 0.78 ALDH1A1 (0.79) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL2090430 0.76 IDO1 (0.53) ALDH1A1MAPTGAACHRM2CHRM1
SCHEMBL22838152 0.76 ALDH1A1 (0.66) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL418619 0.76 ALDH1A1 (0.66) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL4573475 0.75 ALDH1A1 (0.63) ALDH1A1MAPTGAACHRM2BCHE
SCHEMBL19091168 0.75 ALDH1A1 (0.63) ALDH1A1MAPTGAACHRM2BCHE
Hydrochloric Acid SCHEMBL7876474 0.75 MAPT (0.69) ALDH1A1MAPTGAACHRM2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296697-B2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors ABBOTT LABORATORIES (US) 2016-03-29 — — US disclosed
US-20100184787-A1 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2010-07-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184787-A1 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors HTR5A, HTR2C, HTR1E ALDH1A1 1066/4885MAPT 131/4885GAA 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback